60 Degrees Pharmaceuticals, Inc.
SXTP
$2.96
$0.103.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.88M | -2.05M | -2.16M | -4.17M | 430.50K |
| Total Depreciation and Amortization | 16.80K | 15.90K | 14.70K | 11.00K | 22.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.90K | 171.90K | 727.90K | 2.75M | -1.61M |
| Change in Net Operating Assets | 81.50K | 218.90K | -264.00K | 221.20K | 16.50K |
| Cash from Operations | -1.60M | -1.64M | -1.68M | -1.19M | -1.14M |
| Capital Expenditure | -2.70K | 0.00 | -13.80K | -90.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.71M | -2.10K | -1.73M | -40.60K | -9.80K |
| Cash from Investing | 1.70M | -2.10K | -1.75M | -130.60K | -9.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.71M | -- | 5.23M | 5.00K | 1.90M |
| Repurchase of Common Stock | -18.00K | -101.10K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 102.10K | -80.00K | -5.90K | -- |
| Cash from Financing | 1.70M | 1.00K | 5.15M | -900.00 | 1.90M |
| Foreign Exchange rate Adjustments | -9.90K | -2.00K | 1.80K | 1.50K | -800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.79M | -1.64M | 1.72M | -1.32M | 752.20K |